Kiran Naqvi

10PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyHaematological tumoursCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|Nov 07, 2023
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|Jan 15, 2021
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.

Iman Abou Dalle, Hagop M Kantarjian, Farhad Ravandi

|Sep 26, 2019
Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia.

Kiran Naqvi, Elias Jabbour, Jeffrey Skinner

|Jul 17, 2019
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.

Koji Sasaki, Hagop M Kantarjian, Tapan Kadia

|Jun 01, 2019
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia.

Kamal Chamoun, Hagop M Kantarjian, Xuemei Wang

Pageof 2

Frequent Collaborators

8 joint publications

Hagop M Kantarjian

7 joint publications

Elias Jabbour

5 joint publications

Tapan M Kadia

4 joint publications

Naval G Daver